Home › Funds › GROUPAMA ASSET MANAGMENT › IONS

GROUPAMA ASSET MANAGMENT position in IONS

IONIS PHARMACEUTICALS INC · Health Care

GROUPAMA ASSET MANAGMENT reported holding 937,083 shares of IONS (IONIS PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$75.2M, representing 0.99% of its reported portfolio and ranking #27 among its reported holdings. GROUPAMA ASSET MANAGMENT has disclosed IONS holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)937.08K sh
Reported value held$75.20M
Portfolio Weight0.99%
First reportedQ4 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How GROUPAMA ASSET MANAGMENT's IONS position evolved

GROUPAMA ASSET MANAGMENT first disclosed a stake in IONS in Q4 2023 at 357,036 shares (US$18.1M). The position peaked in Q2 2026 at 937,083 shares, worth US$75.2M. Across 11 filings, GROUPAMA ASSET MANAGMENT increased the stake 7 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 937,083 shares valued at US$75.2M — an increase of 112,543 shares quarter over quarter.. Notable position changes include a 28% trim in Q1 2024 (shares rose 10% over the following quarter), a 94% increase in Q2 2024 (shares fell 16% over the following quarter), a 83% increase in Q3 2024 (shares fell 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 357.04K $18.07M New
Q1 2024 257.87K $17.03M Reduce
Q2 2024 500.00K $551.88K Add
Q3 2024 916.06K $13.80M Add
Q4 2024 1.02M $18.55M Add
Q1 2025 1.07M $18.23M Add
Q2 2025 1.16M $26.83M Add
Q3 2025 1.06M $37.44M Reduce
Q4 2025 766.89K $60.67M Reduce
Q1 2026 824.54K $61.91M Add
Q2 2026 937.08K $75.20M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IONS and 13F data

IONS (IONIS PHARMACEUTICALS INC) is a Health Care company. 41 other funds we track also report a position in IONS — the largest reported positions include Two Sigma Investments (US$495.7M), TWO SIGMA ADVISERS, LP (US$241.5M), Tweedy, Browne Co LLC (US$180.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IONS

All IONS fund holders →

FAQ

How long has GROUPAMA ASSET MANAGMENT held IONS?

GROUPAMA ASSET MANAGMENT has disclosed IONS holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

What is GROUPAMA ASSET MANAGMENT's current position in IONS?

As of Q2 2026, GROUPAMA ASSET MANAGMENT holds 937.08K shares of IONS (IONIS PHARMACEUTICALS INC), valued at $75.20M, representing 0.99% of its reported portfolio and ranking #27.

Has GROUPAMA ASSET MANAGMENT been buying or selling IONS?

In the latest 13F filing (Q2 2026), GROUPAMA ASSET MANAGMENT increased its position in IONS. The position peaked in Q2 2026 at 937.08K shares.

Which other funds hold IONS?

Other major institutional holders of IONS include Two Sigma Investments, TWO SIGMA ADVISERS, LP, Tweedy, Browne Co LLC, among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.